Both genetic and environmental factors are known to play an important
role in the development of cancer. To determine whether, among individ
uals who develop cancers, some may have been more susceptible to the m
utagenic effects of environmental agents, skin biopsies were taken fro
m 79 cancer patients with different common types of cancers (e.g., lun
g, breast, bladder, colon, cervix, ovary, brain, vocal cord, uterus, s
kin, testis, stomach, basal cell carcinoma, leukemia, etc.). Fibroblas
t cultures have been established from skin explants from nearly all of
the patients. The sensitivity of some of these cells as well as a num
ber of other fibroblast strains established from ''clinically normal''
individuals to a battery of mutagenic agents (e.g., ethylmethane sulf
onate, methylmethane sulfonate, ethidium bromide, actinomycin D, mitom
ycin C, bleomycin, camptothecin), which induce different kinds of DNA
damage was examined. For the control group of fibroblasts, a normal ra
nge of toxicity for all of the above agents have been established. In
contrast to other mutagens for which sensitivity of all of the control
cell strains lay within a narrow range, large and interesting differe
nces in sensitivity were observed for ethidium bromide. The fibroblast
strains established from fetal tissue were found to be highly resista
nt to ethidium bromide, whereas fibroblasts from two clinically normal
persons exhibited greatly enhanced sensitivity to this agent. The gen
etic or biochemical basis of increased sensitivity or resistance to et
hidium bromide remains to be determined. The sensitivity of cells from
28 cancer patients to a number of the mutagenic agents was also exami
ned. Most of these strains exhibited normal range of sensitivity to th
e mutagens; however, a few showed small but noticeable differences in
sensitivity to specific agents. The fibroblast strains from cancer pat
ients provide a useful resource to examine the genetic and metabolic f
actors that may be important determinants in cancer susceptibility.